Brigatinib for Named Patient Import

Brigatinib for Indian Patients

Brigatinib is a very advanced oral medication, duly approved in the management of metastatic non-small cell lung cancer (NSCLC). Brigatinib is prescribed by Medical Oncologists in India. This is specifically indicated in ALK-positive patients. Developed and promoted by ARIAD Pharmaceuticals, Brigatinib is marketed by the trade name - Alunbrig.

Brigatinib or Alunbrig in India is not accessed through routine domestic sources. It is because Brigatinib in India is not registered formally. But, this will not limit patients in India to procure Brigatinib
through the official import route. Alunbrig is available in three strengths – 30mg, 90mg and 180mg. Alunbrig tablets may be sourced by the Indian patients after applying for Named Patient Import
permit. These permits are strictly given for individual utility.

Brigatinib in India? Get help from Experts.

If your primary physician has suggested the use of Brigatinib or Alunbrig, you may want to expedite the procurement. You can consider our professional assistance in order to reach out to the trusted global sources. The supply channels we put you in touch with are certainly licensed and are definitely authorized to import Brigatinib in India. You can very well take our assistance in completing the important legal documentation process too. We will help you with approach. We also support you in a way the whole process becomes very simple with no complexity.

Email at nhs@noelbiotech.com or call us on + 91 9677010046 / + 91 9929277766.